Avantax Advisory Services, Inc. Royalty Pharma PLC Transaction History
Avantax Advisory Services, Inc.
- $17.6 Billion
- Q2 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 15,793 shares of RPRX stock, worth $568,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,793
Previous 13,399
17.87%
Holding current value
$568,705
Previous $417,000
36.45%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
495Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.68 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$829 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$788 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$649 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...